Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Michaud (Calgary, Canada), D. Vis (London, United Kingdom), H. Robertson (Calgary, Canada), J. Weatherald (Calgary, Canada). Pulmonary sarcoid-like granulomatosis during tumour necrosis factor-alpha inhibition: a scoping review. 3000

Member's Comments

No comment yet.

Related content which might interest you: Tumor necrosis factor-alpha and CD4/CD8 ratio in patients with hypersensitivity pneumonitis Source: International Congress 2016 – ILD pathogenesis Year: 2016 Pulmonary inflammatory myofibroblastic tumour with unusual octreoscan uptake: two reports Source: Eur Respir J 2010; 35: 448-450 Year: 2010 Alveolar macrophages are the main source for tumour necrosis factor-α in patients with sarcoidosis Source: Eur Respir J 2003; 21: 421-428 Year: 2003 Tumor necrosis factor-α and interleukin-6 gene polymorphisms in pulmonary embolism Source: Eur Respir J 2005; 26: Suppl. 49, 520s Year: 2005 Tumor necrosis factor α in chronic pulmonary diseases of children Source: Eur Respir J 2002; 20: Suppl. 38, 193s Year: 2002 Role of tumor necrosis factor alpha in hepatopulmonary syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 562s Year: 2004 Evaluation levels of pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma in lung cancer complicated with metastatic pleurisy Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001 Risk of chemotherapy-induced pulmonary fibrosis is associated with polymorphic tumour necrosis factor-a2 gene Source: Eur Respir J 2002; 19: 912-918 Year: 2002 Tumour necrosis factor gene polymorphisms and childhood wheezing Source: Eur Respir J 2005; 26: 637-646 Year: 2005 A case of Wegener granulomatosis that mimics metastatic pulmonary tumor and progresses with eosinophilia Source: Annual Congress 2007 - Granulomatous lung diseases including sarcoidosis Year: 2007 Implication of leptin, tumor necrosis factor-alpha, interleukin-1 and interleukin-6 in the pathogenesis of wasting in tuberculosis Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection Year: 2006 The levels of tumour necrosis factor-alpha and interleukin-1 in newly diagnosed and multi drug resistant tuberculosis Source: Annual Congress 2004 - Clinical and diagnostic features of tuberculosis Year: 2004 Effects of zinc on the interleukin-1 and tumor necrosis factor in experimental silicosis Source: Eur Respir J 2002; 20: Suppl. 38, 517s Year: 2002 Tumour marker in pulmonary carcinoid Source: Annual Congress 2008 - Various thoracic tumours and interesting cases Year: 2008 Pulmonary lesions in patients with inflammatory bowel disease – the baseline and under anti-tumor necrosis factor therapy. Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017 Inhibited IL-17A ameliorates sarcoid-like granulomatosis in mice Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Should isoniazid prophylaxis be prescribed to the patients under tumor necrosis factor-alpha antagonists independent of tuberculin skin test? Source: International Congress 2015 – Screening strategies in TB Year: 2015 Inflammatory pseudotumour with Hodgkin-like growth pattern: a case report Source: Eur Respir J 2001; 18: Suppl. 33, 398s Year: 2001 Tuberculosis and tumor necrosis factor alpha antagonist: Our experience Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Tumour necrosis factor and lymphotoxin A polymorphisms: a relationship with COPD and its progression? Source: Eur Respir J 2007; 29: 8-10 Year: 2007